EcoDrugPlus

Proteasome Subunit Beta 11

Ensembl ID : ENSLBEG00000018653
Gene Symbol: PSMB11
1 Cross references
168 Possible Orthologues:

Proteasome Subunit Beta 11

Ensembl ID : ENSLBEG00000022295
Gene Symbol: PSMB11
1 Cross references
168 Possible Orthologues:

Proteasome Subunit Beta Type-11-Like

Ensembl ID : ENSLBEG00000023068
Gene Symbol: LOC109982246
3 Cross references
159 Possible Orthologues:

Proteasome Subunit Beta Type-5-Like

Ensembl ID : ENSLBEG00000022234
Gene Symbol: LOC109998372
3 Cross references
203 Possible Orthologues:

Proteasome Subunit Beta Type-8-Like

Ensembl ID : ENSLBEG00000015096
Gene Symbol: LOC109975122
3 Cross references
217 Possible Orthologues:

Proteasome Subunit Beta Type-8-Like

Ensembl ID : ENSLBEG00000024352
Gene Symbol: LOC110002716
3 Cross references
217 Possible Orthologues:

Protein Arginine N-Methyltransferase 5-Like

Ensembl ID : ENSLBEG00000022405
Gene Symbol: LOC109998366
3 Cross references
197 Possible Orthologues:

Protein Arginine N-Methyltransferase 5-Like

Ensembl ID : ENSLBEG00000018599
Gene Symbol: LOC109976420
3 Cross references
197 Possible Orthologues:

Protein Farnesyltransferase Subunit Beta-Like

Ensembl ID : ENSLBEG00000013547
Gene Symbol: LOC109979768
3 Cross references
209 Possible Orthologues:

Protein Kinase C Alpha

Ensembl ID : ENSLBEG00000012411
Gene Symbol: PRKCA
4 Cross references
213 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSLBEG00000021726
Gene Symbol: PRKCB
4 Cross references
207 Possible Orthologues:

Protein Kinase C Beta Type

Ensembl ID : ENSLBEG00000004738
Gene Symbol: LOC109988297
3 Cross references
223 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).